Jane Street’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-149,988
Closed -$3.94M 11994
2025
Q4
$3.94M Buy
149,988
+22,963
+18% +$596K ﹤0.01% 3614
2025
Q3
$2.87M Sell
127,025
-53,679
-30% -$1.11M ﹤0.01% 4300
2025
Q2
$3.59M Sell
180,704
-57,468
-24% -$1.12M ﹤0.01% 3473
2025
Q1
$4.03M Buy
238,172
+67,326
+39% +$1.15M ﹤0.01% 3248
2024
Q4
$3.16M Buy
170,846
+111,164
+186% +$2.17M ﹤0.01% 3359
2024
Q3
$1.3M Buy
59,682
+12,332
+26% +$276K ﹤0.01% 5349
2024
Q2
$929K Sell
47,350
-15,800
-25% -$330K ﹤0.01% 5910
2024
Q1
$1.37M Sell
63,150
-72,656
-53% -$1.8M ﹤0.01% 4824
2023
Q4
$3.93M Buy
135,806
+121,060
+821% +$3.24M ﹤0.01% 3220
2023
Q3
$394K Sell
14,746
-4,985
-25% -$170K ﹤0.01% 6636
2023
Q2
$731K Sell
19,731
-16,139
-45% -$563K ﹤0.01% 5722
2023
Q1
$1.12M Buy
35,870
+9,866
+38% +$318K ﹤0.01% 4795
2022
Q4
$774K Sell
26,004
-25,805
-50% -$923K ﹤0.01% 5407
2022
Q3
$1.98M Sell
51,809
-8,856
-15% -$444K ﹤0.01% 4226
2022
Q2
$3.31M Sell
60,665
-26,288
-30% -$1.44M ﹤0.01% 3290
2022
Q1
$5.43M Buy
86,953
+25,852
+42% +$1.7M ﹤0.01% 2900
2021
Q4
$6.15M Buy
61,101
+18,679
+44% +$1.64M ﹤0.01% 2538
2021
Q3
$3.82M Buy
42,422
+29,807
+236% +$2.71M ﹤0.01% 3194
2021
Q2
$1.16M Buy
12,615
+4,676
+59% +$373K ﹤0.01% 5507
2021
Q1
$767K Sell
7,939
-39,327
-83% -$4.06M ﹤0.01% 5988
2020
Q4
$2.46M Buy
47,266
+33,982
+256% +$1.42M ﹤0.01% 3147
2020
Q3
$532K Buy
+13,284
New +$416K ﹤0.01% 5056
2020
Q2
Sell
-25,954
Closed -$279K 7200
2020
Q1
$279K Buy
+25,954
New +$362K ﹤0.01% 4292

Other funds holding FLGT

Jane Street's FLGT Position: Q1 2026 in Review

Jane Street sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 149,988 shares — an estimated $3.94M sold.

Jane Street first reported a position in FLGT in Q1 2020 and held it in 23 quarters. The position peaked at $6.15M in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Jane Street reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 149,988 Fulgent Genetics shares in Q1 2026, an estimated $3.94M.
  • Jane Street first reported a position in Fulgent Genetics in Q1 2020 and held it in 23 quarters.
  • Jane Street's Fulgent Genetics position peaked at $6.15M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.